1.a. Full Title: Inflammatory and allergy markers as predictors of colorectal cancer risk (CRC): Atherosclerosis Risk in Communities (ARIC) study

[1]  L. Coussens,et al.  Inflammation and Cancer , 2016 .

[2]  J. Cerhan,et al.  History of Allergy and Reduced Incidence of Colorectal Cancer, Iowa Women's Health Study , 2007, Cancer Epidemiology Biomarkers & Prevention.

[3]  A. M. López,et al.  Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women. , 2007, Archives of internal medicine.

[4]  E. Lamont,et al.  NSAIDs and Colorectal Cancer Risk: Do Administrative Data Support a Chemopreventive Effect? , 2007, Journal of General Internal Medicine.

[5]  P. Mitchell,et al.  Association between circulating white blood cell count and long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. , 2006, American journal of epidemiology.

[6]  S. Jee,et al.  White Blood Cell Count and the Risk of Colon Cancer , 2006, Yonsei medical journal.

[7]  R. Sinha,et al.  A prospective study of serum C-reactive protein and colorectal cancer risk in men. , 2006, Cancer research.

[8]  P. Mitchell,et al.  Association between circulating white blood cell count and cancer mortality: a population-based cohort study. , 2006, Archives of internal medicine.

[9]  A. Tamakoshi,et al.  Colorectal Cancer and Serum C-reactive Protein Levels: a Case-control Study Nested in the JACC Study , 2005, Journal of epidemiology.

[10]  T. Erlinger,et al.  WBC count and the risk of cancer mortality in a national sample of U.S. adults: results from the Second National Health and Nutrition Examination Survey mortality study. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[11]  F. Levi-Schaffer,et al.  Eosinophils: ‘new’ roles for ‘old’ cells , 2004, Allergy.

[12]  T. Erlinger,et al.  C-reactive protein and the risk of incident colorectal cancer. , 2004, JAMA.

[13]  W. Willett,et al.  A Prospective Study of Aspirin Use and the Risk for Colorectal Adenoma , 2004, Annals of Internal Medicine.

[14]  K. Yano,et al.  Plasma Fibrinogen as a Predictor of Total and Cause-Specific Mortality in Elderly Japanese-American Men , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[15]  G. Gleich.  Mechanisms of eosinophil-associated inflammation. , 2000, The Journal of allergy and clinical immunology.

[16]  H. Nielsen,et al.  Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue , 1999, The Journal of pathology.

[17]  T. Tezuka,et al.  RANTES mRNA expression in skin and colon of patients with atopic dermatitis. , 1996, International archives of allergy and immunology.

[18]  K. Helzlsouer,et al.  Serum albumin, bilirubin, and uric acid and the anatomic site-specific incidence of colon cancer. , 1994, Journal of the National Cancer Institute.

[19]  G. Friedman,et al.  The leukocyte count and cancer mortality. , 1991, American journal of epidemiology.

[20]  J. Neaton,et al.  Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. , 1985, JAMA.

[21]  T. P. Pretlow,et al.  Eosinophil infiltration of human colonic carcinomas as a prognostic indicator. , 1983, Cancer research.